Article

Microfluidic Platform for Drug Response Profiling in NSCLC Patient-Derived Organoids

2026-06-19

Abstract excerpt

Tumor models that recapitulate 3D architecture are essential for understanding how cellular organization and microenvironmental interactions govern therapeutic response in human cancers. Here, we developed a microfluidic microphysiological system that enables controlled and scalable culture and drug testing of non-small cell lung cancer spheroids and patient-derived organoids. The platform integrated U-shaped micr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fba2be48-0452-581f-8a14-3619bb6837de
DOI: 10.64898/2026.06.17.733025

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Microfluidic Platform for Drug Response Profiling in NSCLC Patient-Derived OrganoidsDOI 10.64898/2026.06.17.733025Read

Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies.Semantic proximity Read

Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncologySemantic proximity Read

Breaking the mold: 3D cell cultures reshaping the future of cancer researchSemantic proximity Read

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironmentsSemantic proximity Read

<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicineSemantic proximity Read

Epithelial‐to‐Mesenchymal Transition (EMT) and Drug Response in Dynamic Bioengineered Lung Cancer MicroenvironmentSemantic proximity Read

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a weekSemantic proximity Read

Microphysiological vascularized solid tumor model for drugs and cell therapies screeningSemantic proximity Read

Tumoroid-on-a-Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic ScreeningSemantic proximity Read

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldSemantic proximity Read

The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid TumorsSemantic proximity Read

Tumor-on-chip platforms for transport phenotyping: decoding CAF-driven barriers to drug delivery.Semantic proximity Read